Genesis Healthcare, Inc.
GENN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $3,906,223 | $4,565,834 | $4,976,650 | $5,373,740 |
| % Growth | -14.4% | -8.3% | -7.4% | – |
| Cost of Goods Sold | $2,256,200 | $2,485,010 | $2,786,908 | $3,036,868 |
| Gross Profit | $1,650,023 | $2,080,824 | $2,189,742 | $2,336,872 |
| % Margin | 42.2% | 45.6% | 44% | 43.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $541,396 | $531,534 | $279,041 | $315,243 |
| SG&A Expenses | $541,396 | $531,534 | $279,041 | $317,554 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,311 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $594,513 | $593,672 | $1,979,817 | $170,029 |
| Operating Income | $1,055,510 | $1,487,152 | $209,925 | $182,729 |
| % Margin | 27% | 32.6% | 4.2% | 3.4% |
| Other Income/Exp. Net | -$1,162,487 | -$1,477,924 | -$584,765 | -$1,152,328 |
| Pre-Tax Income | -$106,977 | $9,228 | -$374,840 | -$969,599 |
| Tax Expense | -$3,610 | $1,754 | -$2,423 | -$10,427 |
| Net Income | -$58,963 | $14,619 | -$235,231 | -$578,982 |
| % Margin | -1.5% | 0.3% | -4.7% | -10.8% |
| EPS | -0.53 | 0.14 | -2.33 | -6.15 |
| % Growth | -478.6% | 106% | 62.1% | – |
| EPS Diluted | -0.53 | 0.1 | -2.33 | -6.15 |
| Weighted Avg Shares Out | 111,851 | 107,286 | 101,007 | 94,217 |
| Weighted Avg Shares Out Dil | 111,851 | 165,314 | 101,007 | 94,217 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $135,439 | $180,392 | $463,738 | $499,382 |
| Depreciation & Amortization | $107,833 | $123,159 | $220,896 | $255,786 |
| EBITDA | $136,295 | $312,779 | $309,794 | -$214,431 |
| % Margin | 3.5% | 6.9% | 6.2% | -4% |